Testing effectiveness (Phase 2)Ended earlyNCT02096042What this trial is testingPhase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)Who this might be right forLeukemia M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06696183What this trial is testingGilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive TreatmentWho this might be right forAML - Acute Myeloid Leukemia Technische Universität Dresden 60
Large-scale testing (Phase 3)UnknownNCT00025402What this trial is testingChemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia III. Medizinische Klinik Mannheim 1,000
Testing effectiveness (Phase 2)Study completedNCT00739141What this trial is testingConditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.Who this might be right forLeukemiaMyelodysplastic SyndromeNon-Hodgkins Lymphoma+2 more Memorial Sloan Kettering Cancer Center 86
Not applicableWithdrawnNCT06362031What this trial is testingExplore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart ReviewWho this might be right forAcute Myeloid Leukemia AbbVie
Post-approval studies (Phase 4)UnknownNCT01339988What this trial is testingBusulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)Who this might be right forAcute LeukemiasChronic LeukemiasMyelodysplastic Syndrome+1 more Tel-Aviv Sourasky Medical Center 10
Large-scale testing (Phase 3)UnknownNCT00002869What this trial is testingInterferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaWho this might be right forLeukemia Medical Research Council 800
Early research (Phase 1)Ended earlyNCT03110354What this trial is testingDS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)Who this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute Daiichi Sankyo 28
Not applicableStudy completedNCT04169022What this trial is testingAML Cell Immunotherapy Using Chimeric Antigen Receptor T-cellsWho this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire de Besancon 86
Not applicableUnknownNCT02759822What this trial is testingHaploidentical Hematopoietic Stem Cell Transplantation for Acute LeukemiasWho this might be right forLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma Leonardo Javier Arcuri 30
Early research (Phase 1)Not Yet RecruitingNCT07583303What this trial is testingBSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 MutationWho this might be right forRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 19
Early research (Phase 1)Not Yet RecruitingNCT06463327What this trial is testingACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AMLWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes TC Biopharm 69
Very early researchUnknownNCT06541405What this trial is testingSafety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia Base Therapeutics (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00462605What this trial is testingMS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more National Cancer Institute (NCI) 24
Not applicableWithdrawnNCT01176422What this trial is testingTelomere and TelomeraseWho this might be right forAcute Myeloid Leukemia University of Kansas Medical Center
Testing effectiveness (Phase 2)Study completedNCT01830361What this trial is testingTrial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AMLWho this might be right forAcute Myeloid Leukemia Technische Universität Dresden 18
Testing effectiveness (Phase 2)Looking for participantsNCT07392242What this trial is testingThe Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Ended earlyNCT04679194What this trial is testingStudy of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCTWho this might be right forAML/MDS Mana Therapeutics 11